Mutant huntingtin represses CBP, but not p300, by binding and protein degradation

• Published in: Molecular and cellular neuroscience 2005-09, Vol.30 (1), p.12-23
• Main Authors: Cong, Shu-Yan, Pepers, Barry A., Evert, Bernd O., Rubinsztein, David C., Roos, Raymund A.C., van Ommen, Gert-Jan B., Dorsman, Josephine C.
• Format: Article
• Language: English
• Subjects: Animals; CREB-Binding Protein; E1A-Associated p300 Protein; Gene Expression Regulation; Huntingtin Protein; Huntington Disease - metabolism; Huntington Disease - physiopathology; Nerve Degeneration - metabolism; Nerve Degeneration - physiopathology; Nerve Tissue Proteins - genetics; Nerve Tissue Proteins - metabolism; Nuclear Proteins - genetics; Nuclear Proteins - metabolism; PC12 Cells; Protein Binding; Rats; Trans-Activators - metabolism; Transcription, Genetic; Transfection
• ISSN: 1044-7431; 1095-9327
• DOI: 10.1016/j.mcn.2005.05.003

Huntington's disease can be used as a model to study neurodegenerative disorders caused by aggregation-prone proteins. It has been proposed that the entrapment of transcription factors in aggregates plays an important role in pathogenesis. We now report that the transcriptional activity of CBP is already repressed in the early time points by soluble mutant huntingtin, whereas the histone acetylase activity of CBP/p300 is gradually diminished over time. Mutant huntingtin bound much stronger to CBP than normal huntingtin, possibly contributing to repression. Especially at the later time points, CBP protein level was gradually reduced via the proteasome pathway. In sharp contrast, p300 was unaffected by mutant huntingtin. This selective degradation of CBP was absent in spinocerebellar ataxia 3. Thus, mutant huntingtin specifically affects CBP and not p300 both at the early and later time points, via multiple mechanisms. In addition to the reduction of CBP, also the altered ratio of these closely related histone acetyltransferases may affect chromatin structure and transcription and thus contribute to neurodegeneration.